Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
Meta Platforms (Facebook)
META
|
+$446M |
| 3 |
Johnson & Johnson
JNJ
|
+$306M |
| 4 |
Evergy
EVRG
|
+$288M |
| 5 |
Walmart Inc
WMT
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$596M |
| 2 |
Booking.com
BKNG
|
+$519M |
| 3 |
Amazon
AMZN
|
+$518M |
| 4 |
Eli Lilly
LLY
|
+$268M |
| 5 |
UnitedHealth
UNH
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.51% |
| 2 | Technology | 14.39% |
| 3 | Financials | 11.76% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Real Estate | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Safety Insurance
SAFT
$1.52B
| $33.3M | 0.04% |
390,100
+9,700
| +3% | +$805K |
|
|
TARO
627
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $33.2M | 0.04% |
287,000
+25,600
| +10% | +$2.81M |
|
628
Park Aerospace
PKE
$828M
| $33.1M | 0.04% |
1,428,000
+142,700
| +11% | +$2.77M |
|
|
RTEC
629
DELISTED
Rudolph Technologies Inc
RTEC
| $33M | 0.04% |
1,114,836
+224,536
| +25% | +$6.83M |
|
|
SNR
630
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $33M | 0.04% |
4,358,200
+574,800
| +15% | +$4.57M |
|
631
Warner Bros
WBD
$69.3B
| $33M | 0.04% |
+1,198,850
| New | +$28.6M |
|
632
Methode Electronics
MEI
$602M
| $32.9M | 0.04% |
816,400
-61,100
| -7% | -$2.5M |
|
|
GBNK
633
DELISTED
Guaranty Bancorp
GBNK
| $32.8M | 0.04% |
1,099,120
+389,200
| +55% | +$11.9M |
|
|
RST
634
DELISTED
ROSETTA STONE INC
RST
| $32.8M | 0.04% |
2,043,200
+21,000
| +1% | +$315K |
|
|
BFYT
635
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $32.7M | 0.04% |
1,012,300
+57,800
| +6% | +$1.76M |
|
636
Radware
RDWR
$1.22B
| $32.7M | 0.04% |
1,295,200
-10,100
| -0.8% | -$235K |
|
|
UHT
637
Universal Health Realty Income Trust
UHT
$573M
| $32.6M | 0.04% |
510,300
-38,800
| -7% | -$2.39M |
|
|
CORR
638
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $32.6M | 0.04% |
867,900
+116,971
| +16% | +$4.35M |
|
|
SBNY
639
DELISTED
Signature Bank
SBNY
| $32.6M | 0.04% |
255,174
+189,600
| +289% | +$24.9M |
|
640
Unum
UNM
$14.5B
| $32.6M | 0.04% |
881,816
+399,716
| +83% | +$16.7M |
|
|
EIGI
641
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $32.5M | 0.04% |
3,271,373
+1,269,194
| +63% | +$10.9M |
|
|
IBA
642
DELISTED
Industrias Bachoco SAB De C.V.
IBA
| $32.5M | 0.04% |
562,400
+9,400
| +2% | +$548K |
|
643
Marvell Technology
MRVL
$195B
| $32.3M | 0.04% |
1,506,562
-3,480,982
| -70% | -$74.3M |
|
644
Haverty Furniture Companies
HVT
$441M
| $32.3M | 0.04% |
1,494,900
-52,841
| -3% | -$1.05M |
|
645
CytomX Therapeutics
CTMX
$760M
| $32.3M | 0.04% |
1,411,500
+450,300
| +47% | +$11.5M |
|
646
SAP
SAP
$236B
| $32.1M | 0.04% |
277,900
-242,400
| -47% | -$27.4M |
|
647
Vanda Pharmaceuticals
VNDA
$314M
| $32M | 0.03% |
1,681,250
+41,200
| +3% | +$689K |
|
|
AMAG
648
DELISTED
AMAG Pharmaceuticals
AMAG
| $32M | 0.03% |
1,641,100
+96,300
| +6% | +$2.13M |
|
649
KB Home
KBH
$3.42B
| $31.8M | 0.03% |
1,169,100
+383,200
| +49% | +$10.3M |
|
650
Varonis Systems
VRNS
$4.82B
| $31.8M | 0.03% |
1,281,900
-133,800
| -9% | -$3.21M |
|
Similar funds
Jim Simons's Q2 2018 Portfolio in Review
As of Q2 2018, Jim Simons held 3,750 positions worth $91.7B, up 0.34% from $91.4B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons withdrew a net $3.9B in Q2 2018, closing 524 positions and reducing 1,111 holdings. Its most notable exit was Booking.com, an estimated $519M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, Jim Simons opened a new position in Apple worth $707M.
- Jim Simons's largest Q2 2018 buy was Apple: 15,275,332 shares worth $707M.
- Jim Simons added most to Johnson & Johnson in Q2 2018, an estimated $306M increase.
- Jim Simons's biggest Q2 2018 reduction was Home Depot, cutting an estimated $596M.
- Jim Simons fully exited Booking.com in Q2 2018, selling an estimated $519M.
- Jim Simons's ten largest holdings make up 9.1% of its $91.7B portfolio in Q2 2018.
- Jim Simons opened 412 new positions and closed 524 in Q2 2018.
- Jim Simons's portfolio value rose 0.34% quarter-over-quarter to $91.7B.
Based on Renaissance Technologies's 13F filing for Q2 2018, filed 13 Aug 2018.